Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Homeostatic Regulation of Sleep in Short Sleepers
NCT07584538Not yet recruiting
- Sponsor
- CHU Montpellier
- Start
- Apr 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by CHU Montpellier. Primary endpoint: Decrease in EEG spectral power in the delta band (0.5-4 Hz) at Day 17. Planned start Apr 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07584538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07584538.